Evidence map›Paper›PMID 38902183›Full record

ArticleSeminars in oncology nursing2024

The Use of Novel Instrumented Socks to Detect Changes in Daily Life Mobility During an Exercise Intervention in Prostate Cancer Survivors Treated with Androgen Deprivation Therapy.

Deanne C Tibbitts, Sydnee A Stoyles, Martina Mancini, Mahmoud El-Gohary, Fay B Horak, Nathan F Dieckmann, Kerri M Winters-Stone

Abstract read
In one paragraph

Article in Seminars in oncology nursing, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Deanne C TibbittsKnight Cancer Institute, Oregon Health & Science University, Portland, OR, USA; Division of Oncological Sciences, Oregon Health & Science University, Portland, OR, USA.
Sydnee A StoylesSchool of Nursing, Oregon Health & Science University, Portland, OR, USA.
Martina ManciniDepartment of Neurology, Oregon Health & Science University, Portland, OR, USA.
Mahmoud El-GoharyAPDM Wearable Technologies, Clario, Portland, OR, USA.
Fay B HorakDepartment of Neurology, Oregon Health & Science University, Portland, OR, USA.
Nathan F DieckmannSchool of Nursing, Oregon Health & Science University, Portland, OR, USA.
Kerri M Winters-StoneKnight Cancer Institute, Oregon Health & Science University, Portland, OR, USA; Division of Oncological Sciences, Oregon Health & Science University, Portland, OR, USA. Electronic address: wintersk@ohsu.edu.

Funding

Scholars in Women's Health Research Across the LifespanK12HD043488 · NICHD · OREGON HEALTH & SCIENCE UNIVERSITY · PI MYATT, LESLIE · 2002 to 2023
$10.4M
Preventing Falls and Frailty in Prostate Cancer Survivors: GET FIT ProstateR01CA222605 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI WINTERS-STONE, KERRI M · 2018 to 2022
$3.3M
Mobility in Daily Life and Falls in Parkinson's Disease: Potential for RehabilitationR01HD100383 · NICHD · OREGON HEALTH & SCIENCE UNIVERSITY · PI HORAK, FAY BAHLING, MANCINI, MARTINA · 2020 to 2024
$2.6M
Oregon BIRCWH: Scholars in Women's Health Research Across the LifespanK12AR084221 · NIAMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI LESLIE MYATT · 2023 to 2026
$2.2M
NCI NIH HHS R01 CA222605NIAMS NIH HHS K12 AR084221NICHD NIH HHS K12 HD043488NICHD NIH HHS R01 HD100383
6 · The paper itself

Abstract

objectivesTo describe changes in daily life mobility in prostate cancer survivors treated with androgen deprivation therapy (ADT) after a 6-month exercise intervention using novel instrumented socks and to identify characteristics of participants who exhibited changes in daily life mobility.

methodsA subset of participants in a fall prevention exercise trial completed objective tests and patient-reported surveys of physical functioning, and wore instrumented socks for up to 7 days to measure daily life mobility. Changes in cadence, double support proportion, and pitch angle of the foot at toe-off were selected as measures of daily life mobility previously found to be different in men exposed to ADT for prostate cancer versus controls. Daily life mobility was compared from baseline to 6 months using paired t-tests. Characteristics of responders who improved their daily life mobility were compared to nonresponders using two-sample t-tests, Chi-squared proportion tests, or Fisher's Exact Tests.

resultsOur sample included 35 prostate cancer survivors (mean age 71.6 ± 7.8 years). Mean cadence, double support proportion, and pitch angle at toe-off did not change significantly over 6 months of exercise, but 14 participants (40%) improved in at least two of three daily life mobility measures ("responders"). Responders were characterized by lower physical functioning, lower cadence in daily life, fewer comorbidities, and better social and mental/emotional functioning.

conclusionsCertain daily life mobility measures potentially impacted by ADT could be measured with instrumented socks and improved by exercise. Men who start with lower physical functioning and better social and mental/emotional functioning appear most likely to benefit, possibly because they have more to gain from exercise and are able to engage in a 6-month intervention. IMPLICATIONS FOR NURSING PRACTICE: Technology-based approaches could provide nurses with an objective measure of daily life mobility for patients with chronic illness and detect who is responding to rehabilitation.

Indexed as

Activities of Daily LivingAndrogen AntagonistsCancer SurvivorsExercise TherapyProstatic NeoplasmsAgedAged, 80 and overHumansMaleMiddle AgedQuality of LifeAndrogen Antagonistsandrogen deprivation therapyexercisegait qualityprostate cancerwearable sensors

Identifiers

PMID38902183
PMCPMC11344597

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.